Acute Myeloid Leukemia
Research results from C. Koenecke and colleagues update understanding of acute myeloid leukemia
Published in Hematology Week, July 14th, 2008
"Between July 2000 and June 2003 a total of 21 patients with high-risk acute myeloid leukemia (AML; n = 14), AML after myelodysplastic syndrome (MDS; n = 6) or advanced MDS (n = 1) were treated with an 188-Re labelled anti-CD66 antibody in the conditioning regimen for allogeneic stem cell transplantation. Radioimmunotherapy (RIT) was followed by standard full-dose conditioning with busulfan and high-dose cyclophosphamide in 11 patients and reduced intensity conditioning regimen in 10 patients," investigators in Bremen, Germany report.
"All patients received an unmanipulated allogeneic graft from alternative donors (n = 15) or a HLA-identical familiy donor (n = 6). With...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week
Source: Hematology Week (2008-07-14)
More Articles from Hematology Week
- American Cancer Society
News from Cancer: Risk factors for deadly form of lymphoma - Abdominal Aortic Aneurysm
Surgeons Role in Abdominal Aortic Aneurysms Mortality Examined - Autopsy
Data from University of Hamburg advance knowledge in autopsy - Cancer Vaccines
Research findings from University of Texas update understanding of cancer vaccines - Chromatography
Reports summarize chromatography study results from University of Toronto - Cook Medical
U.S. Multicenter Trial Shows Positive Results Using Cook Medical's Zenith Abdominal Aortic Aneurysm Endovascular Stent Compared to Open Surgical Repair - More from this issue of Hematology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
